HIV drug resistance report 2017

by Hiwot Haile-Selassie, Michael R. Jordan, Elliot Raizes et al.
World Health Organization, United States Centers for Disease Control and Prevention, The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2017

82 pp. 5.0 MB
http://apps.who.int/iris/bitstream/10665/255896/1/9789241512831-eng.pdf?ua=1

This second HIV drug resistance (HIVDR) report provides an update on recent population levels of HIVDR covering the period 2014–2016. The report includes data from 16 nationally representative surveys from 14 countries estimating resistance in: adults initiating ART (PDR), children younger than 18 months newly diagnosed with HIV, and adults on ART (acquired HIV drug resistance or ADR). To contextualize results from representative HIVDR surveys, the report is supported by systematic reviews of the published literature on PDR in adults, children and adolescents, and ADR in paediatric and adult populations.

(Visited 13 times, 1 visits today)
This entry was posted in Essential Medicines, General, HIV - AIDS - STI. Bookmark the permalink.